22 May 2013
Keywords: Aegerion Pharma, Lomitapide, HoFH, Genetic disorder, USA, Europe
Article | 07 March 2012
Emerging US biotech firm Aegerion Pharmaceuticals (Nasdaq: AEGR) has submitted a New Drug Application to the US Food and Drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 March 2012
6 March 2012
21 May 2013
© 2013 thepharmaletter.com